All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Rare Oslo bio IPO blows out on day one

The Oslo Stock Exchange is set to host a rare biotech IPO. Nordic Nanovector, a Norwegian company that is developing antibody-radio conjugates, is seeking to raise Nkr400m ($50m) of new capital.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree